查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1465959

新型药物输送系统市场：按给药途径、模式和最终用户划分 - 2024-2030 年全球预测

Novel Drug Delivery Systems Market by Route of Administration, Mode, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年新型给药系统市场规模为138.3亿美元，预计2024年将达150亿美元，2030年将达255.7亿美元，复合年增长率为9.17%。

新型药物递送系统（NDDS）是指製药中使用的先进方法和技术来配製可以透过非传统方法递送到体内的药物。调查方法包括各种旨在将药物化合物输送到体内特定部位以提高疗效、控制药物释放和提高患者依从性的技术和製程。慢性病的流行、老年人口的显着增加以及控製药物控制释放技术的进步正在影响新型药物输送系统市场的成长。政府对新型药物输送系统的核准正在加速市场成长。输送治疗剂和与新型药物传输系统相关的药物所需的现有限制、併发症和专业知识可能会限制其扩充性和广泛使用。新型药物输送系统开发的持续进步和自行注射装置的日益普及预计将为市场提供成长机会。

主要市场统计
基准年[2023] 138.3亿美元
预测年份 [2024] 150亿美元
预测年份 [2030] 255.7亿美元
复合年增长率（%） 9.17%

给药途径：在慢性病管理中越来越多地采用注射给药系统

注射药物输送系统旨在将药物直接输送到身体循环。这些系统通常优选用于快速起效、生物有效性低的药物和标靶药物传递。口服给药系统是最常见的途径，并且由于易于给药、患者依从性和成本效益而成为首选。此类别的创新旨在提高溶解度和吸收、控制释放以及精确定位作用部位，从而最大限度地减少副作用。肺部药物输送系统用于呼吸系统疾病的局部治疗和某些药物的全身输送。可实现非侵入性、快速的全身性吸收，包括雾化器、定量吸入器和干粉吸入器。经皮给药系统透过皮肤给药并使其在全身发挥作用。在口服途径不合适或首选以避免首过代谢的情况下，贴剂、凝胶和微针技术已取得进展。比较分析表明，注射剂在药物生物有效性和标靶递送方面具有优势，但在患者便利性方面落后。口服製剂方便且具成本效益，生物有效性各不相同。另一方面，经皮系统可提供持续递送和良好的患者依从性，但可有效递送的药物类型有限。

最终用户：由于预算限制和服务更多患者群体的需要，医院越来越多地使用新型给药系统

医院是新型给药系统的最大领域。它主要关注的是以患者为中心的护理和改善的结果。医院正在寻找安全、有效并提供高度控制药物释放的药物传输系统。该研究中心优先考虑药物输送系统的创新和最尖端科技。该研究中心专注于先进的药物传输机制，以实现药物的精确标靶化和释放。专科诊所部门正在寻找专门针对特定医疗领域或疾病的药物传递系统。专科诊所偏好针对特异性疾病的输送系统，以优化治疗结果。所有细分市场都强调创新，研究中心专注于尖端的交付方法，其次是需要针对特定疾病进行创新的专科诊所。医院要求系统能够与现有的健康资讯科技无缝整合，以改善监控和合规性。

区域洞察

美洲新型药物输送系统 (NDDS) 市场受到强大的技术进步和研发方面的大量投资的推动，重点是个人化医疗。大型製药公司的存在和完善的医疗保健基础设施有助于该地区的领先地位。美国FDA法律规范为创新药物输送解决方案的引入和采用提供了有利的环境。由于意识的提高和医疗保健支出的增加，南美 NDDS 市场正在兴起。欧洲是实施 NDDS 最先进的国家，得到了强大的政府支持和高品质的医疗保健系统的支持。同时，中东和非洲也正在透过战略伙伴关係和增加对医疗保健领域的投资来适应这一进展。由于经济成长和医疗保健投资的增加，亚太地区 NDDS 市场正在显着成长。中国和日本凭藉其技术力和庞大的医疗支出处于领先地位。此外，印度和东南亚製药业的成长对 NDDS 市场的扩张做出了重大贡献。

FPNV定位矩阵

FPNV定位矩阵对于评估新的给药系统市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对新型药物输送系统市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.新型给药系统市场规模及预测如何？

2.在新型给药系统市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.新型给药系统市场的技术趋势与法规结构是什么？

4.新型给药系统市场主要厂商的市场占有率为何？

5. 进入新型给药系统市场的合适型态与策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病盛行率和老年人口显着增加
      • 药物控制控制释放技术的进展
      • 政府核准新的给药系统
    • 抑制因素
      • 与新药物输送系统相关的现有限制
    • 机会
      • 新型药物输送系统的开发不断取得进展
      • 越来越多地采用自行注射装置
    • 任务
      • 施用治疗剂和药物所需的併发症和专业知识
  • 市场区隔分析
    • 给药途径：更多采用注射给药系统进行慢性病管理
    • 最终用户：预算限制和容纳更多病患的需求正在增加医院中新型给药系统的使用。
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章 新药物输送系统市场：依给药途径

  • 注射给药系统
  • 口服给药系统
  • 肺部给药系统
  • 经皮给药系统

第七章按模式分類的新给药系统市场

  • 受管制药物传输系统
  • 调控药物传输系统
  • 标靶给药系统

第八章新药物输送系统市场：依最终用户分类

  • 医院
  • 研究中心
  • 专科诊所

第九章北美及南美新给药系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区新型给药系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲新型给药系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 全新的一站式药物输送商店
    • Viridian Therapeutics 宣布与药物传输创新者 Enable Injections 合作
    • Kindeva Drug Delivery 收购高峰会 Biosciences

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-02026C4CB9B9

[190 Pages Report] The Novel Drug Delivery Systems Market size was estimated at USD 13.83 billion in 2023 and expected to reach USD 15.00 billion in 2024, at a CAGR 9.17% to reach USD 25.57 billion by 2030.

Novel drug delivery systems (NDDS) refer to the advanced methods and technologies used in pharmaceuticals to formulate medicines that can be delivered to the body in non-traditional ways. The market for novel drug delivery systems encompasses diverse technologies and methodologies designed to transport pharmaceutical compounds to specific parts of the body to enhance efficacy, control drug release, and improve patient compliance. The prevalence of chronic diseases, a significant rise in the geriatric population, and advancements in controlled drug release technologies are influencing the growth of the novel drug delivery systems market. Government approvals for novel drug delivery systems are accelerating the market's growth. Existing limitations associated with novel drug delivery systems, complications, and expertise required in delivering therapeutics and drugs may limit scalability and widespread usage. Ongoing advancements in developing novel drug delivery systems and the rising adoption of self-injectable devices are expected to provide growth opportunities in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 13.83 billion
Estimated Year [2024] USD 15.00 billion
Forecast Year [2030] USD 25.57 billion
CAGR (%) 9.17%

Route of Administration: Rising adoption of injectable drug delivery systems for chronic disease management

Injectable drug delivery systems are designed for direct delivery of drugs into the body's circulation. These systems are typically preferred for rapid onset of action, for drugs with poor oral bioavailability, and for targeted drug delivery. Oral drug delivery systems are the most common route, favored for ease of administration, patient compliance, and cost-effectiveness. Innovations in this category aim to improve solubility and absorption, controlled release, and precise targeting to the site of action to minimize side effects. Pulmonary drug delivery systems are employed for localized treatment of respiratory diseases and systemic delivery of certain drugs. They offer non-invasive rapid systemic absorption, highlighting nebulizers, metered-dose inhalers, and dry powder inhalers. Transdermal drug delivery systems administer drugs through the skin for systemic effects. Preferred when oral routes are unsuitable or to avoid first-pass metabolism, advancements include patches, gels, and microneedle technologies. A comparative analysis reveals that injectables excel in terms of drug bioavailability and targeted delivery but lag in patient convenience. Oral systems offer convenience and cost efficiency, yet vary in bioavailability. Pulmonary methods provide fast absorption and are relatively easy to use, while transdermal systems offer sustained delivery and good patient compliance, though with potential limits on the types of drugs that can be effectively delivered.

End-User: Increasing use of novel drug delivery systems in the hospital due to budget constraints and the necessity to cater to a larger patient base

Hospitals represent the largest segment of novel drug delivery systems. Their primary concern is delivering patient-centered care with improved outcomes. Hospitals seek drug delivery systems that are safe and effective with a high degree of control over drug release. Research centers prioritize innovation and cutting-edge technologies in drug delivery systems. They focus on advanced drug delivery mechanisms that allow precise targeting and release of drugs. The specialty clinics segment seeks specialized and targeted drug delivery systems that support their focus on particular medical disciplines or diseases. Specialty clinics prefer disease-specific delivery systems that optimize therapeutic outcomes. While all segments value innovation, research centers emphasize cutting-edge delivery methods, followed by specialty clinics requiring disease-specific innovations. Hospitals have a strong need for systems that integrate seamlessly with existing health information technologies for better monitoring and compliance.

Regional Insights

The novel drug delivery systems (NDDS) market in the Americas is driven by robust technological advancements and significant investments in research and development, with a strong focus on personalized medicine. The presence of key pharmaceutical companies and a well-established healthcare infrastructure contribute to the pioneering position of this region. The regulatory framework facilitated by the FDA in the United States sets a conducive environment for introducing and adopting innovative drug delivery solutions. South America's market for NDDS is emerging with growing awareness and increasing healthcare expenditure. Europe has the highest adoption of NDDS, backed by strong governmental support and high-quality healthcare systems. In contrast, the Middle East and Africa are also adapting to the advancements owing to increasing strategic partnerships and investments in healthcare sectors. The Asia-Pacific region is witnessing significant growth in the NDDS market attributed to growing economies and increasing healthcare investments. Due to their technological capabilities and substantial healthcare spending, China and Japan are major countries. Additionally, the growing pharmaceutical sectors in India and Southeast Asia are contributing significantly to the expansion of the NDDS market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Novel Drug Delivery Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Novel Drug Delivery Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Novel Drug Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca Plc, Bayer AG, Boston Scientific Corporation, Bristol Myers Squibb Company, Cospheric LLC, Enable Injections, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Merit Medical Systems, Inc., Mo-Sci Corporation, Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Polysciences Inc., Sanofi S.A., Societal CDMO, Spectrum Pharmaceuticals, Inc., Terumo Medical Corporation, Thermo Fisher Scientific Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Novel Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Injectable Drug Delivery Systems
    • Oral Drug Delivery Systems
    • Pulmonary Drug Delivery Systems
    • Transdermal Drug Delivery Systems
  • Mode
    • Controlled Drug Delivery Systems
    • Modulated Drug Delivery Systems
    • Targeted Drug Delivery Systems
  • End-User
    • Hospital
    • Research Centers
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Novel Drug Delivery Systems Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Novel Drug Delivery Systems Market?

3. What are the technology trends and regulatory frameworks in the Novel Drug Delivery Systems Market?

4. What is the market share of the leading vendors in the Novel Drug Delivery Systems Market?

5. Which modes and strategic moves are suitable for entering the Novel Drug Delivery Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of Chronic Diseases and Significant Rise in Geriatric Population
      • 5.1.1.2. Advancements in Controlled Drug Release Technologies
      • 5.1.1.3. Government Approvals for Novel Drug Delivery Systems
    • 5.1.2. Restraints
      • 5.1.2.1. Existing Limitations Associated with Novel Drug Delivery System
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing Advancements for Development of Novel Drug Delivery Systems
      • 5.1.3.2. Rising Adoption of Self-Injectable Devices
    • 5.1.4. Challenges
      • 5.1.4.1. Complications and Expertise Required in Delivering Therapeutics and Drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Route of Administration: Rising adoption of injectable drug delivery systems for chronic disease management
    • 5.2.2. End-User: Increasing use of novel drug delivery systems in the hospital due to budget constraints and the necessity to cater to a larger patient base
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Novel Drug Delivery Systems Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Injectable Drug Delivery Systems
  • 6.3. Oral Drug Delivery Systems
  • 6.4. Pulmonary Drug Delivery Systems
  • 6.5. Transdermal Drug Delivery Systems

7. Novel Drug Delivery Systems Market, by Mode

  • 7.1. Introduction
  • 7.2. Controlled Drug Delivery Systems
  • 7.3. Modulated Drug Delivery Systems
  • 7.4. Targeted Drug Delivery Systems

8. Novel Drug Delivery Systems Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospital
  • 8.3. Research Centers
  • 8.4. Specialty Clinics

9. Americas Novel Drug Delivery Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Novel Drug Delivery Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Novel Drug Delivery Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novel drug delivery one-stop shop
    • 12.3.2. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
    • 12.3.3. Kindeva Drug Delivery acquires Summit Biosciences

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. NOVEL DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NOVEL DRUG DELIVERY SYSTEMS MARKET DYNAMICS
  • FIGURE 7. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. NOVEL DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. NOVEL DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NOVEL DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. NOVEL DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. NOVEL DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023